Results 41 to 50 of about 9,019 (165)

Extraprostatic incidental findings on prostate mpMRI: A pictorial review from the ESUR junior network [PDF]

, 2023
The role of multiparametric MRI (mpMRI) in prostate cancer setting is increasingly consolidated and, as a result, its usage in clinical practice is in exponential growth.
Sharaf D. E., Ciabattoni R., Sachs C., Cuocolo R., Brembilla G., Alvarez-Hornia Perez E., Zawaideh J., Ponsiglione A., Stanzione A., Sofia C., Campo I., Causa-Andrieu P.   +11 more
core   +2 more sources

Histopathological features of prostate cancer conspicuity on multiparametric MRI: protocol for a systematic review and meta-analysis

BMJ Open, 2020
Introduction Multiparametric MRI (mpMRI) has improved risk stratification for men with suspected prostate cancer. Indeed, mpMRI-visible tumours tend to be larger and of higher pathological grade than mpMRI-invisible tumours; however, concern remains ...
Alex Freeman, Mark Emberton, Daniel Kelly, Joseph M Norris, Benjamin S Simpson, Rhys Ball, Alex Kirkham, Hayley C Whitaker, Lina M Carmona Echeverria   +8 more
doaj   +1 more source

Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy.

PLoS ONE, 2020
BackgroundTo determine the added value of preoperative prostate multiparametric MRI (mpMRI) supplementary to clinical variables and their role in predicting post prostatectomy adverse findings and biochemically recurrent cancer (BCR).MethodsAll ...
Kevin Sandeman, Juho T Eineluoto, Joona Pohjonen, Andrew Erickson, Tuomas P Kilpeläinen, Petrus Järvinen, Henrikki Santti, Anssi Petas, Mika Matikainen, Suvi Marjasuo, Anu Kenttämies, Tuomas Mirtti, Antti Rannikko   +12 more
doaj   +1 more source

Role of multi-parametric MRI of the prostate for screening and staging: Experience with over 1500 cases

Asian Journal of Urology, 2017
Objective: Contemporary prostate cancer (PCa) screening modalities such as prostate specific antigen (PSA) and digital rectal examination (DRE) are limited in their ability to predict the detection of clinically significant disease.
Geoffrey Gaunay, Vinay Patel, Paras Shah, Daniel Moreira, Simon J. Hall, Manish A. Vira, Michael Schwartz, Jessica Kreshover, Eran Ben-Levi, Robert Villani, Ardeshir Rastinehad, Lee Richstone   +11 more
doaj   +1 more source

Value of prostate-specific antigen density in negative or equivocal lesions on multiparametric magnetic resonance imaging

Urology Research and Practice, 2020
Objective: The prostate-specific antigen density (PSAD) is an accessory tool when suspecting prostate cancer. Multiparametric magnetic resonance imaging (mpMRI) of the prostate has a high rate of false negatives.
Luis Rico, Pablo Contreras, Gonzalo Vitagliano, Hernando Rios Pita, Carlos Ameri, Leandro Blas   +5 more
doaj   +1 more source

Can the predictive value of multiparametric MRI for prostate cancer be improved by a liquid biopsy with SelectMDx?

Cancer Reports, 2021
Background SelectMDx is a urinary biomarker test for determining prostate cancer risk. Aim In a group of patients with a biopsy proven prostate cancer (PCa) who had undergone a multi parametric Magnetic Resonance Imaging (mpMRI) and urinary biomarker ...
Mohammad Sajjad Rahnama'i, Christian Bach, Maximilian Schulze‐Hagen, Christiane K Kuhl, Thomas Alexander Vögeli   +4 more
doaj   +1 more source

Utility of prostate multiparametric MRI (mpMRI) for recurrent prostate cancer after radiation therapy and cryotherapy.

, 2016
71 Background: We evaluated the accuracy of mpMRI for identifying locally recurrent prostate cancer after primary radiotherapy and cryotherapy. Methods: Between 2009-2015, 61 patients with evidence of rising PSA after external-beam radiotherapy (EBRT) (
Evan Kovac, Andrew J. Stephenson, Cristina Magi-Galluzzi, Andrei Purysko, Eric A. Klein, J. Stephen Jones   +5 more
core   +1 more source

Human biomarker navigator

iMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li, Qian Zhang, Zijie Wang, Zeping Gui, Jing Liu, Jingda Li, Maojun Jiang, Zukang Chang, Qingqing Han, Bendong Yang, Tariq Saeed, Jun Li, Jinghan Jia, Chenghu Song, Tong Shao, Tianhuan Peng, Xueying Zhang, Pingping Guo, Jun Luo, Gangao Yang, Yuan Wan, Gokhan Zengin, Quan Yuan, Lingru Li, Xiaohui Fan, Yang Luo, Lvyun Zhu, Yanfei Zheng, Wenjun Mao, Wenlong Sun   +29 more
wiley   +1 more source

Feasibility of multi-parametric magnetic resonance imaging in detection and local staging of prostatic carcinoma

African Journal of Urology, 2020
Background The objective of this study was to assess the feasibility of multi-parametric magnetic resonance imaging (mpMRI) in detection, localization and local staging of prostate cancer (Pca).
Abul-fotouh Ahmed, Hesham El-Helaly, Sayed Elawady, Tarek Elzayat, Gamal Abdelhamid, Mohammed M. Agha, Ahmed Fahim   +6 more
doaj   +1 more source

MRI utility in predicting extraprostatic extension of prostate cancer and biochemical recurrence after radical prostatectomy

Nowotwory, 2021
INTRODUCTION: The study aimed to evaluate the performance of multiparametric magnetic resonance imaging (mpMRI) and the Martini model to predict extraprostatic extension (EPE) and biochemical recurrence (BCR) of prostate cancer (PCa).
Natalia Majchrzak, Piotr Cieśliński, Tomasz Milecki, Maciej Głyda, Katarzyna Karmelita-Katulska   +4 more
doaj   +1 more source